- Home
- ARVN vs THQ Comparison
ARVN vs THQ Comparison
Compare ARVN & THQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARVN
- THQ
- Stock Information
- Founded
- ARVN 2015
- THQ 2014
- Country
- ARVN United States
- THQ United States
- Employees
- ARVN 430
- THQ N/A
- Industry
- ARVN Biotechnology: Pharmaceutical Preparations
- THQ Finance Companies
- Sector
- ARVN Health Care
- THQ Finance
- Exchange
- ARVN Nasdaq
- THQ Nasdaq
- Market Cap
- ARVN 676.2M
- THQ 714.6M
- IPO Year
- ARVN 2018
- THQ N/A
- Fundamental
- Price
- ARVN $9.45
- THQ $18.18
- Analyst Decision
- ARVN Buy
- THQ
- Analyst Count
- ARVN 23
- THQ 0
- Target Price
- ARVN $17.61
- THQ N/A
- AVG Volume (30 Days)
- ARVN 2.6M
- THQ 158.9K
- Earning Date
- ARVN 11-04-2025
- THQ 01-01-0001
- Dividend Yield
- ARVN N/A
- THQ 7.53%
- EPS Growth
- ARVN N/A
- THQ N/A
- EPS
- ARVN N/A
- THQ N/A
- Revenue
- ARVN $372,800,000.00
- THQ N/A
- Revenue This Year
- ARVN $1.01
- THQ N/A
- Revenue Next Year
- ARVN N/A
- THQ N/A
- P/E Ratio
- ARVN N/A
- THQ N/A
- Revenue Growth
- ARVN 299.57
- THQ N/A
- 52 Week Low
- ARVN $5.90
- THQ $15.29
- 52 Week High
- ARVN $29.61
- THQ $20.38
- Technical
- Relative Strength Index (RSI)
- ARVN 57.54
- THQ 64.56
- Support Level
- ARVN $9.01
- THQ $18.11
- Resistance Level
- ARVN $9.55
- THQ $18.31
- Average True Range (ATR)
- ARVN 0.49
- THQ 0.22
- MACD
- ARVN -0.10
- THQ 0.00
- Stochastic Oscillator
- ARVN 44.37
- THQ 77.03
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About THQ abrdn Healthcare Opportunities Fund Shares of Beneficial Interest
abrdn Healthcare Opportunities Fund is a non-diversified closed-end fund in the United States. The fund's investment objective is to seek current income and long-term capital appreciation through investments in U.S. and non-U.S. companies.